Diffuse hyperpigmented plaques as cutaneous manifestation of multicentric Castleman disease and treatment with thalidomide: Report of three cases
- 1 August 2011
- journal article
- research article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 65 (2) , 430-432
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- High-concentration (20 μg g−1 ) tacalcitol ointment in the treatment of facial psoriasis: an 8-week open-label clinical trialBritish Journal of Dermatology, 2010
- Randomized, double-blind clinical trial to evaluate the efficacy of topical tacalcitol and sunlight exposure in the treatment of adult nonsegmental vitiligoBritish Journal of Dermatology, 2009
- Multicentric Castleman Disease with Cutaneous Manifestations: Report of 2 Cases and Comparison with Systemic PlasmacytosisDermatology, 2007
- Indurated nodules and plaques showing a dense plasma cell infiltrate as a cutaneous manifestation of Castleman's diseaseBritish Journal of Dermatology, 2007
- Topical tacalcitol and 308‐nm monochromatic excimer light: a synergistic combination for the treatment of vitiligoPhotodermatology, Photoimmunology & Photomedicine, 2006
- Tacalcitol and narrow-band phototherapy in patients with vitiligoClinical and Experimental Dermatology, 2006
- The aetiology and management of Castleman disease at 50 years: translating pathophysiology to patient careBritish Journal of Haematology, 2005
- Alleviation of Systemic Manifestations of Castleman's Disease by Monoclonal Anti-Interleukin-6 AntibodyNew England Journal of Medicine, 1994